Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EuroapiEAPIF 52 OCF Margin % is 25.13% as of Dec. 2025, which is 214% above its 10-year median of 8.01. GuruFocus rates EAPIF with a GF Score™ of 52/100 and a GF Value™ of $3.31 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 964 Drug Manufacturers companies, Euroapi ranks better than 65.56% on this metric.
The historical rank and industry rank for Euroapi's OCF Margin % or its related term are showing as below:
EAPIF'
s OCF Margin % Range Over the Past 10 Years
Min: 0.5 Med: 8.01 Max: 15.07
Current: 15.15
During the past 7 years, the highest OCF Margin % of Euroapi was 15.07%. The lowest was 0.50%. And the median was 8.01%.
EAPIF's OCF Margin % is ranked better than 65.56% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs EAPIF: 15.15
Euroapi OCF Margin % Related Terms
Euroapi OCF Margin % Historical Data
* Premium members only.
The historical data trend for Euroapi's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euroapi OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euroapi's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Euroapi's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euroapi (EAPIF) has a OCF Margin % of 25.13% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Euroapi and its competitors. This is 214% above median its historical median of 8.01. Over the past decade, Euroapi's OCF Margin % has ranged from 0.50 to 15.07. According to the industry distribution chart, Euroapi ranks #332 out of 964 companies in the Drug Manufacturers industry, placing it in the top 34.4%.
Is Euroapi's OCF Margin % too high?
Euroapi's current OCF Margin % of 25.13% is 214% above median its 10-year median of 8.01. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 15.07. The Drug Manufacturers industry median OCF Margin % is 10.04. Euroapi's value of 25.13% is 150.4% above this industry median. Based on the distribution chart, Euroapi ranks #332 out of 964 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Euroapi has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euroapi ranks #332 out of 964 companies for OCF Margin %. This puts Euroapi in the upper half of its industry. The industry median OCF Margin % is 10.04. Euroapi's value of 25.13% is 150.4% above this benchmark. Historically, Euroapi's own OCF Margin % has ranged from 0.50 to 15.07 over the past decade. While the company's 10-year median is 8.01 vs. the industry median of 10.04, Euroapi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euroapi's current OCF Margin % of 25.13% is 150.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Euroapi and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euroapi's current OCF Margin % is 25.13%, which is 214% above median its own 10-year median of 8.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (EAPIF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.31, compared to a current price of $1.51 — trading 54.4% below its estimated fair value. The current OCF Margin % is 25.13%, which is 214% above median its 10-year median of 8.01 and 150.4% above the Drug Manufacturers industry median of 10.04. Euroapi's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Euroapi (EAPIF), the current OCF Margin % is 25.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euroapi (EAPIF) Overvalued in 2026?
Based on GuruFocus' analysis, Euroapi stock appears to be undervalued.
The current stock price of $1.51 is trading 54.4% below its estimated GF Value™ of $3.31.
GuruFocus considers Euroapi to be Possible Value Trap.
Key valuation signals for EAPIF:
OCF Margin %: 25.13% (214% above median its 10-year median of 8.01)
GF Value™: $3.31 vs. price of $1.51 (54.4% below fair value)
Industry Position: 150.4% above the Drug Manufacturers median (#332 of 964)
No single metric tells the full story. See the EAPIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
52GF Score
Get the complete analysis for EAPIF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EAPIF has been successfully added to your 
